An analysis by Stock Options Channel highlights potential options strategies for Biogen Inc (BIIB). Selling the $125 put offers a 2.88% return if it expires worthless, while a covered call strategy at the $130 strike yields 6.04% if the stock is called away; probabilities of these outcomes are estimated at 62% and 49%, respectively, based on current analytical data. The analysis notes implied volatility in the put and call contracts is 37% and 35% respectively, compared to a trailing twelve month volatility of 29%.
The provided financial news details options strategies for Biogen Inc. (BIIB), whose shares are currently trading at $127.22. For investors considering acquiring BIIB, selling the $125.00 strike put contract, with a current bid of $3.60, could result in an effective purchase price of $121.40 per share, representing a discount from the current market price. Analytical data suggests a 62% probability of this put expiring worthless, which would generate a 2.88% return on the cash commitment, or an 18.77% annualized YieldBoost. Alternatively, for investors holding BIIB shares, a covered call strategy involving selling the $130.00 strike call, bid at $4.90, offers a potential total return of 6.04% if the stock is called away by the August 15th expiration. There is a 49% assessed probability of this call expiring worthless, in which case the premium collected would represent a 3.85% additional return, or a 25.10% annualized YieldBoost. A key observation from the article is the disparity between the implied volatilities of these options (37% for the put, 35% for the call) and BIIB's actual trailing twelve-month historical volatility of 29%, indicating that current option prices reflect expectations of greater future price fluctuations than recently experienced.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
